Side-by-side comparison of AI visibility scores, market position, and capabilities
India event trading and prediction market platform at $25M annualized GMV growing 30% MoM; YC W22 $1M+ Java Capital/Soma Capital-backed targeting 50M Indian users for cricket and election outcome trading.
Better Opinions is an India-based event trading and prediction market platform — backed by Y Combinator (W22) with $1 million+ raised in a pre-seed round from Java Capital and Soma Capital — enabling Indian users to trade on real-world event outcomes (cricket match results, election outcomes, stock price movements, entertainment events) through a prediction market interface, operating at $25 million in annualized GMV with 30% month-over-month growth and targeting the nearly 50 million active Indian users who represent approximately 25% of all demat account holders in the country. Founded in 2021 and headquartered in India, Better Opinions operates in the intersection of online gaming and financial prediction markets that Indian regulators are actively defining under SEBI (Securities and Exchange Board of India) and the Ministry of Electronics and Information Technology.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.